Xpresys Lung

Xpresys Lung

For the first time, there is a solution for the overtreatment of pulmonary lung nodules. The Xpresys Lung test is independent of risk factors used to assess the probability of malignancy (age, nodule size, and smoking history pack-years, COPD diagnosis), and provides pulmonologists with molecular evidence to better assess lung nodule patients before they undergo an invasive diagnostic procedure that may be harmful and costly to the health care system.

The Xpresys Lung test provides physicians with information about the probability that a nodule is benign, and may provide added assurance for recommending serial CT surveillance for their patients.

 
You are now leaving this website. If you would like to continue, click Continue.
Cancel Continue